SAFEs, Convertible Notes, and Priced Rounds: A Founder’s Plain-English Guide

SAFEs, convertible notes, and priced rounds are three ways to sell a piece of your company, and the choice affects your dilution, your timeline, and your legal exposure. A SAFE is a contract that converts into stock later, with no interest and no repayment date. A convertible note is a loan that converts into stock later, carrying an interest rate and a maturity date. A priced round sells stock now at an agreed valuation using a full set of financing documents, and all three are sales of securities that require an exemption from SEC registration.

Most founders choose an instrument because a friend used it or an accelerator handed them a template. That is how founders end up giving away more of the company than they intended, or raising money in a way that creates a compliance problem before the product ships. This guide covers what each instrument does, what each one costs you in ownership, and the rules that apply to all three, for the startup founders this firm serves alongside real estate sponsors and fund managers.

What is a SAFE, and how does it work?

A SAFE is a Simple Agreement for Future Equity. Y Combinator introduced the form in 2013 and released a revised version in 2018. It is a short contract in which an investor gives the company money now in exchange for the right to receive stock later, when a defined event happens. That event is usually the company’s next priced equity financing, though most SAFEs also convert on a sale of the company or a dissolution.

A SAFE is not debt. There is no interest rate, no maturity date, and no obligation to repay. If the company never raises a priced round and never sells, the SAFE may simply never convert. That structure is why SAFEs are fast and cheap to sign, and it is also why the terms inside them deserve more attention than founders usually give them.

What do the valuation cap and the discount actually do?

Two terms drive almost all of the economics.

• Valuation cap. The cap sets a ceiling on the valuation used to convert the investor’s money into shares. If you raise a SAFE at a $5 million cap and later price your round at $20 million, the SAFE holder converts as though the company were worth $5 million. They get roughly four times the stock their dollars would have bought in the priced round.
• Discount. The discount gives the investor a percentage off the price paid by new investors in the priced round. Where a SAFE has both a cap and a discount, it typically converts at whichever produces the better price for the investor, not the better price for you.

Some SAFEs carry a most favored nation clause, entitling the holder to the best terms you give any later SAFE investor. Others attach a pro rata side letter letting the investor maintain their ownership percentage in future rounds. Both are negotiable, and both bite at the priced round.

Why does pre-money versus post-money matter?

The 2013 SAFE was a pre-money instrument. The 2018 version is post-money. The difference is not cosmetic. Under a post-money SAFE, the investor’s ownership percentage is fixed at signing and does not shrink when you issue additional SAFEs. Every dollar of dilution from later SAFEs comes out of the founders and the option pool instead. Founders who raise on several post-money SAFEs over eighteen months are often surprised at the conversion math, because each new SAFE dilutes them and no one else.

What is a convertible note, and how is it different from a SAFE?

A convertible note is a loan. The investor lends the company money, the note accrues interest at a stated rate, and the note has a maturity date. On a qualified financing, usually defined as a priced round above a threshold amount, the principal and accrued interest convert into equity, generally with a valuation cap, a discount, or both.

The maturity date is the meaningful difference. When a note matures without a qualifying financing, the investor is a creditor holding a debt that is due. In practice the parties usually negotiate an extension or a conversion at a set valuation, but that outcome depends on the investor’s willingness. A founder with three notes maturing in the same quarter and no priced round in sight is negotiating from a weak position.

Notes still appear regularly outside the pure venture track, particularly with individual investors who want the protections of being a lender. They carry more documentation than a SAFE and less than a priced round.

What is a priced round, and when does it make sense?

A priced round sells stock at an agreed valuation today. Nothing is deferred. You and the investors agree on a pre-money valuation, the investors buy preferred stock, and the ownership split is settled at closing.

A priced round carries a full document set, usually including a stock purchase agreement, an amended certificate of incorporation creating the preferred stock, an investors’ rights agreement, a voting agreement, and a right of first refusal and co-sale agreement. Those documents cover liquidation preference, anti-dilution protection, board composition, protective provisions over major decisions, and information rights.

The tradeoff is straightforward. A priced round costs more, takes longer, and hands investors governance rights. It also ends the uncertainty: everyone knows what they own, and nothing is waiting to convert on terms you have not modeled.

SAFEs, convertible notes, and priced rounds compared

The same five questions separate the three instruments.

• Is it debt? A SAFE is not. A convertible note is. A priced round is an equity sale, so the question does not apply.
• Does it set a valuation now? A SAFE defers valuation and may set a cap. A convertible note does the same. A priced round sets the valuation at closing.
• Is there a deadline? A SAFE has no maturity date. A convertible note matures and becomes payable. A priced round has nothing pending after closing.
• What does the paperwork look like? A SAFE is a few pages. A note is a note plus, in many deals, a purchase agreement. A priced round is a set of five or more negotiated documents.
• Who controls the company afterward? SAFEs and notes usually leave governance untouched until conversion. A priced round typically adds a board seat and protective provisions.

Which instrument fits your raise?

The instrument follows the situation, not the trend. A few practical markers:

• A SAFE tends to fit a first raise from angels or an accelerator cohort, where the amount is modest, speed matters, and no one can price the company credibly yet.
• A convertible note tends to fit a bridge between rounds, or an investor who wants creditor status and a hard date on the calendar.
• A priced round tends to fit a raise large enough that a lead investor will do diligence and negotiate terms, or a company that has accumulated enough deferred instruments that another one would make the cap table unmanageable.

Entity type matters too. The standard SAFE and the standard priced-round documents assume a Delaware corporation with authorized preferred stock. If you are an LLC, a template pulled from an accelerator website does not fit, and forcing it creates problems that surface at the worst possible moment.

Why all three are securities offerings

This is the part that gets skipped. A SAFE is a security. A convertible note is a security. Preferred stock is a security. Selling any of them means you are conducting a securities offering, and every securities offering must either be registered with the SEC or fit an exemption from registration.

Nearly every startup raise relies on Regulation D, and within it Rule 506(b) or Rule 506(c). The choice governs how you are permitted to find investors:

• Rule 506(b) prohibits general solicitation. You cannot advertise the raise, post it publicly, or pitch a room of strangers. You may include up to 35 non-accredited purchasers who meet a sophistication standard, and if you do, specific information must be delivered to them.
• Rule 506(c) permits public advertising of the raise, but every purchaser must be an accredited investor and you must take reasonable steps to verify that status. Checking a box on a questionnaire is not verification under 506(c).

Our 506(b) versus 506(c) guide works through that choice in detail. Whichever you use, a Form D must be filed with the SEC within 15 days after the first sale, and most states require their own notice filing, typically with a fee and its own deadline. Those filings apply to a SAFE round exactly as they apply to a priced round. For the broader picture of how private offerings fit together, see private placements explained.

Do startups on SAFEs need a PPM?

Not always, and the answer turns on who is buying. In a Rule 506 offering sold only to accredited investors, Regulation D does not mandate a specified disclosure document. When non-accredited purchasers participate in a 506(b) offering, the rule requires that defined categories of information be furnished to them, which in practice means a private placement memorandum.

The antifraud rules are a separate matter and they never switch off. It is unlawful to make a material misstatement or to omit a material fact in connection with the sale of a security, regardless of the instrument or the exemption. That obligation covers your pitch deck, your projections, your emails, and what you say on a call. We address that directly in what needs to be in writing in an investor pitch deck.

The practical translation: a founder raising $400,000 on SAFEs from ten accredited angels usually needs correctly drafted SAFEs, an investor questionnaire, a Form D, and state notice filings. A founder taking money from non-accredited friends and family, or raising a larger amount from investors who expect real disclosure, usually needs a full document set. Our document suite page lists what a complete package contains, and the 2026 Reg D PPM pricing guide lays out what drives the cost.

The mistakes that cost founders the most

• Stacking SAFEs without modeling the conversion. Four SAFEs at four different caps, signed over a year, convert simultaneously at the priced round. Founders routinely discover their real ownership for the first time at that moment.
• Treating the cap as a valuation. A cap is a ceiling on the conversion price, not a statement that the company is worth that number. Telling an investor otherwise is a disclosure problem, not a negotiating flourish.
• Advertising a 506(b) raise. Posting the round on LinkedIn, pitching at a public demo event, or emailing a purchased list is general solicitation. It can break the exemption you are relying on, and the fix after the fact is far more expensive than the structure would have been.
• Verbal side deals. A promise of a board seat, a pro rata right, or a better cap that lives only in a text message becomes a dispute later. If it was agreed, it belongs in the documents.
• Skipping Form D and state filings. These are short filings with real deadlines. Missing them is quiet until a later financing or an acquirer runs diligence and finds the gap.

How to move forward

You do not need to become a securities lawyer. You need to know which instrument you are using, what it will do to your cap table, and which exemption your raise sits under. That is a short conversation, and it is far cheaper before the money arrives than after.

The work of building something people want, and convincing others to fund it, is the hard part. The paperwork behind it should never be the thing that stops you.

If you are deciding between a SAFE, a note, and a priced round right now, bring the specifics: how much you are raising, from whom, and on what timeline. Those three answers usually settle the question in one call.

Frequently asked questions

Is a SAFE a security?

Yes. A SAFE is an investment contract that gives the holder a right to future equity, which makes it a security. Selling SAFEs is a securities offering, so it requires an exemption from SEC registration, and the related filings such as Form D and state notice filings apply in the same way they would to a sale of stock.

What is the difference between a valuation cap and a discount?

A valuation cap sets a ceiling on the company valuation used to convert an investor’s money into shares. A discount gives the investor a set percentage off the per-share price paid by investors in the priced round. When a SAFE or note contains both, it generally converts using whichever term gives the investor more shares.

What happens if a convertible note matures before the company raises a priced round?

The note becomes a debt that is due. In practice the company and the investor usually negotiate an extension, a conversion at an agreed valuation, or new terms, but that outcome depends on the investor agreeing. This is the principal risk that distinguishes a convertible note from a SAFE, which has no maturity date.

Can I sell SAFEs to friends and family who are not accredited investors?

Only under a Rule 506(b) offering, which permits up to 35 non-accredited purchasers who meet a sophistication standard and requires that defined categories of information be furnished to them. Rule 506(c), which allows public advertising of the raise, requires that every purchaser be an accredited investor with verified status. Including non-accredited investors raises the disclosure obligation, so it should be structured deliberately rather than by default.

Do I need to file a Form D for a SAFE round?

Yes. A Form D notice filing is due with the SEC within 15 days after the first sale of securities in a Regulation D offering, and a SAFE round is a Regulation D offering. Most states also require their own notice filing, generally with a fee and a separate deadline, in each state where an investor is located.

Should I start with SAFEs or go straight to a priced round?

It depends on size, speed, and whether the company can be priced credibly. Smaller and faster raises from angels usually fit a SAFE. Raises large enough to attract a lead investor who will negotiate terms, or companies already carrying several deferred instruments, usually justify a priced round. The right answer comes from your specific cap table and timeline, not from a default.

This article provides general educational information about startup financing instruments and securities law. It does not constitute legal advice, and reading it does not create an attorney-client relationship. Attorney advertising. Prior results do not guarantee similar outcomes. For guidance on your specific raise, speak with a PPM LAWYERS attorney.